trial · primary record
Fluorouracil
Advanced Esophageal Adenocarcinoma
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 382 |
| Primary completion | 2028-11-08 |
| Primary endpoint | Overall survival (OS) |
| Registry ID | NCT05677490 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:30.347Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05677490
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Fluorouracil · approval
- Fluorouracil · compound